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uclear assembly happens every cell 
division. So it’s no surprise that nuclear 
assembly factors are overworked dur-
ing embryogenesis, when proliferation is maxi-
mal. But there’s no rest for one weary factor, 
called BAF-1, who has many jobs left to do even 
when embryogenesis is over, report Margalit et al. 
on page 661.
BAF-1 is enriched at the nuclear periphery 
and is required for the capture of chromosomes 
in reforming nuclei. It binds to histones, DNA, 
and nuclear envelope proteins including lamin 
and emerin.
Mutations to lamin and emerin, which are also 
crucial for nuclear assembly, somehow cause 
human diseases that manifest later in life, when 
cell division has lagged. In previous studies, the 
group found that knocking down the activity of 
BAF-1 in worms leads to embryonic death. They 
wondered, however, whether BAF-1, like lamin 
and emerin, might have functions later in life.
To investigate this question, they used BAF-1–
null worms that survived embryogenesis thanks 
to maternal BAF-1 supplies. These survivors 
displayed a diverse but reproducible array of 
tissue-specifi   c defects. The defects suggested 
that BAF-1 promotes distal tip cell migration, 
muscle cell integrity, gonad and germline devel-
opment, and the correct timing of epidermal 
seam cell fusion—a process that literally seals 
the worm’s skin.
BAF-1 delayed seam cell fusion by binding 
to the promoter and repressing the expression of 
the gene for a fusion factor called EFF-1. This 
newly described transcriptional regulatory ac-
tivity might also explain BAF-1’s other tissue-
specific functions. 
Cellular career decisions 
start early
T
here’s always one or two kids in every class who are already certain what 
they want to be when they grow up. Gerhart and colleagues now report 
on page 649 that certain cells of the early embryo are no different.
The team is interested in how cells commit to becoming skeletal muscle, 
which requires the expression of a transcription factor called MyoD. This 
expression was thought to start in the somites. But George-Weinstein’s group 
discovered that they could detect MyoD mRNA in the blastocyst—a whole day 
before somites form, when cells are thought to be still pluripotent.
MyoD-expressing cells isolated from the blastocyst were capable of 
differentiating into skeletal muscle in culture. This ability did not mean, 
however, that the cells were already committed to muscle differentiation. It 
was possible that the MyoD mRNA was nonfunctional. Indeed, no MyoD 
protein was detectable at this stage.
To investigate whether MyoD-positive blastocyst cells were stably committed, 
the team introduced them into early cardiac muscle and nervous tissue of the embryo. MyoD-negative cells 
adopted the same fate as their surrounding cells, whereas MyoD-positive cells did not. A small number of 
MyoD-positive cells also ended up in these foreign environments as part of normal development. Such 
immigrants continued to express MyoD, although they remained undifferentiated, as the necessary 
inductive signals for skeletal muscle development were presumably missing.
When MyoD cells were removed from the foreign tissues and cultured, they promptly started 
turning into skeletal muscle. Seems you can take the MyoD cell out of the muscle, but you can’t take 
the muscle out of the embryonic MyoD cell. 
Failure to form a nice neat seam (arrow, left) is just one of the many late-in-life defects 
of worms that lack BAF (right).
A MyoD positive embryonic cell (red) keeps its identity 
even in the foreign environment of the heart.